298 related articles for article (PubMed ID: 15297385)
1. Protein glycation: a firm link to endothelial cell dysfunction.
Wautier JL; Schmidt AM
Circ Res; 2004 Aug; 95(3):233-8. PubMed ID: 15297385
[TBL] [Abstract][Full Text] [Related]
2. Advanced glycation end products, their receptors and diabetic angiopathy.
Wautier JL; Guillausseau PJ
Diabetes Metab; 2001 Nov; 27(5 Pt 1):535-42. PubMed ID: 11694852
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
4. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.
Wautier MP; Chappey O; Corda S; Stern DM; Schmidt AM; Wautier JL
Am J Physiol Endocrinol Metab; 2001 May; 280(5):E685-94. PubMed ID: 11287350
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis impairment by the NADPH oxidase-triggered oxidative stress at the bone-implant interface: Critical mechanisms and therapeutic targets for implant failure under hyperglycemic conditions in diabetes.
Hu XF; Wang L; Xiang G; Lei W; Feng YF
Acta Biomater; 2018 Jun; 73():470-487. PubMed ID: 29649637
[TBL] [Abstract][Full Text] [Related]
6. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products accelerate rat vascular calcification through RAGE/oxidative stress.
Wei Q; Ren X; Jiang Y; Jin H; Liu N; Li J
BMC Cardiovasc Disord; 2013 Mar; 13():13. PubMed ID: 23497312
[TBL] [Abstract][Full Text] [Related]
8. Shixiang Plaster, a Traditional Chinese Medicine, Promotes Healing in a Rat Model of Diabetic Ulcer Through the receptor for Advanced Glycation End Products (RAGE)/Nuclear Factor kappa B (NF-κB) and Vascular Endothelial Growth Factor (VEGF)/Vascular Cell Adhesion Molecule-1 (VCAM-1)/Endothelial Nitric Oxide Synthase (eNOS) Signaling Pathways.
Fei J; Ling YM; Zeng MJ; Zhang KW
Med Sci Monit; 2019 Dec; 25():9446-9457. PubMed ID: 31825949
[TBL] [Abstract][Full Text] [Related]
9. Eucommia ulmoides Ameliorates Glucotoxicity by Suppressing Advanced Glycation End-Products in Diabetic Mice Kidney.
Do MH; Hur J; Choi J; Kim M; Kim MJ; Kim Y; Ha SK
Nutrients; 2018 Feb; 10(3):. PubMed ID: 29495397
[No Abstract] [Full Text] [Related]
10. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes.
Yamagishi S
Exp Gerontol; 2011 Apr; 46(4):217-24. PubMed ID: 21111800
[TBL] [Abstract][Full Text] [Related]
11. [Protein glycation and endothelium dysfunction].
Grossin N; Wautier JL
J Soc Biol; 2007; 201(2):175-84. PubMed ID: 17978751
[TBL] [Abstract][Full Text] [Related]
12. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway.
Guo ZJ; Niu HX; Hou FF; Zhang L; Fu N; Nagai R; Lu X; Chen BH; Shan YX; Tian JW; Nagaraj RH; Xie D; Zhang X
Antioxid Redox Signal; 2008 Oct; 10(10):1699-712. PubMed ID: 18576917
[TBL] [Abstract][Full Text] [Related]
13. Role of advanced glycation end products in cellular signaling.
Ott C; Jacobs K; Haucke E; Navarrete Santos A; Grune T; Simm A
Redox Biol; 2014; 2():411-29. PubMed ID: 24624331
[TBL] [Abstract][Full Text] [Related]
14. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
[TBL] [Abstract][Full Text] [Related]
15. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses.
Basta G; Lazzerini G; Massaro M; Simoncini T; Tanganelli P; Fu C; Kislinger T; Stern DM; Schmidt AM; De Caterina R
Circulation; 2002 Feb; 105(7):816-22. PubMed ID: 11854121
[TBL] [Abstract][Full Text] [Related]
16. Edaravone protected human brain microvascular endothelial cells from methylglyoxal-induced injury by inhibiting AGEs/RAGE/oxidative stress.
Li W; Xu H; Hu Y; He P; Ni Z; Xu H; Zhang Z; Dai H
PLoS One; 2013; 8(9):e76025. PubMed ID: 24098758
[TBL] [Abstract][Full Text] [Related]
17. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy.
Yamagishi S; Nakamura K; Matsui T
Curr Drug Discov Technol; 2006 Mar; 3(1):83-8. PubMed ID: 16712466
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: The role of advanced glycation end products in progression and complications of diabetes.
Goh SY; Cooper ME
J Clin Endocrinol Metab; 2008 Apr; 93(4):1143-52. PubMed ID: 18182449
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
